Atlas Trials

A Phase 2 Trial Evaluating SNC-102 in Drug-Induced Tardive Dyskinesia

Clinical trial NCT02064010 · WITHDRAWN

Trial details

NCT number
NCT02064010
Sponsor
Synchroneuron Inc.
Status
WITHDRAWN
Phase
Phase 2
Study type
INTERVENTIONAL
Drug-induced Tardive Dyskinesia
Start date
2014-02-01
Primary completion
2015-01-01
Enrollment
0

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.